Opthea (ASX:OPT) said that there remained material uncertainty as to its ability to continue as a "going concern," according to a Wednesday Australian bourse filing.
The company noted it continues an active discussion with investors as required by a development funding agreement to explore possible options to deliver the best outcome for the firm and its shareholders.
The firm said it plans to use the net proceeds from any current or future offering or capital raise to advance clinical development, chemistry, manufacturing and controls, regulatory activities of any new asset, and for general corporate purposes.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.